Drug Enforcement Administration August 2010 – Federal Register Recent Federal Regulation Documents

Robert F. Hunt, D.O. Revocation of Registration
Document Number: 2010-20243
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Tony T. Bui, M.D.; Revocation of Registration
Document Number: 2010-20242
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Robert Wayne Mosier, D.O.; Denial of Application
Document Number: 2010-20237
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Hilmes Distributing, Inc.; Dismissal of Proceeding
Document Number: 2010-20233
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Dewey C. Mackay, M.D.; Revocation of Registration
Document Number: 2010-20211
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Hung Thien Ly, M.D.; Revocation of Registration
Document Number: 2010-20209
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Peter W.S. Grigg, M.D.; Revocation of Registration
Document Number: 2010-20201
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Nicholas J. Jerrard, M.D.; Revocation of Registration
Document Number: 2010-20194
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Beverley P. Edwards, M.D.; Revocation of Registration
Document Number: 2010-20193
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
James Stephen Ferguson, D.M.D.; Revocation of Registration
Document Number: 2010-20192
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction
Document Number: 2010-19348
Type: Rule
Date: 2010-08-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is correcting a final rule that appeared in the Federal Register of March 18, 2004. The final rule pertained to the scheduling of N-Benzylpiperazine (BZP), and contained an error regarding the potency of BZP relative to amphetamine. Although DEA used the correct figures in arriving at its scheduling determination, the agency is publishing this correction to provide an official statement of the actual figures. This correction
Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction
Document Number: 2010-19345
Type: Proposed Rule
Date: 2010-08-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is correcting a notice of proposed rulemaking that appeared in the Federal Register of September 8, 2003. The proposed rule pertained to the scheduling of N- Benzylpiperazine (BZP), and contained an error regarding the potency of BZP relative to amphetamine. Although DEA used the correct figures in arriving at its scheduling determination, the agency is publishing this correction to provide an official statement of the actual figures. This
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-19078
Type: Notice
Date: 2010-08-04
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.